BioTech/Drugs - N/A, N/A, NL
Temple Therapeutics is a pharmaceutical clinical development company with a global footprint. We focus on diseases where abnormal tissue growth and dysfunction are common hallmarks and lead to fibrosis, pain, infertility and cancers. Surprisingly, there are either no, limited or completing ineffective therapies or diagnostics, yet it impacts hundreds of millions of people worldwide.BIOSURGERY – POST-SURGICAL TISSUE FIBROSIS/ADHESION PREVENTION -First local therapeutic (surgiceutical) entering phase 3 development-Category leader, no competitors in late stage clinical developmentENDOMETRIOSIS-First non-invasive blood test to diagnose endometriosis-Novel non-hormonal therapeutic developed -ZERO programs in clinical developmentONCOLOGY-Novel targeted therapy for recurrent, sensitive, & platinum resistant ovarian cancer in development-Novel Ph3 drug leveraging blood-brain-barrier delivery platform for leptomeningeal carcinomatosis from breast cancer-LIMITED therapies & poor outcomes for women
reCAPTCHA
Gmail
Mobile Friendly
YouTube
Google Analytics